Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Hodgkin's Lymphoma Refractory/Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00038545
What this trial is testing

A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT05260957
What this trial is testing

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

Who this might be right for
Refractory Non-Hodgkin LymphomaRelapsed Non Hodgkin LymphomaAggressive Non-Hodgkin Lymphoma
Lazaros Lekakis 22
Testing effectiveness (Phase 2)Ended earlyNCT03488251
What this trial is testing

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma
Molecular Templates, Inc. 8
Early research (Phase 1)Temporarily pausedNCT04746131
What this trial is testing

Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT05338931
What this trial is testing

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Non Hodgkin Lymphoma
AbClon 82
Early research (Phase 1)Looking for participantsNCT07052305
What this trial is testing

NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
Washington University School of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT00117988
What this trial is testing

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT02576496
What this trial is testing

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Hematological MalignanciesMultiple MyelomaHodgkin's Lymphoma+1 more
Mundipharma Research Limited 106
Testing effectiveness (Phase 2)Ended earlyNCT00295880
What this trial is testing

Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT01491841
What this trial is testing

IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Anne Beaven, MD 33
Very early researchUnknownNCT05444322
What this trial is testing

RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Who this might be right for
Mantle Cell LymphomaDiffuse Large B-cell LymphomaFollicular Lymphoma
He Huang 18
Early research (Phase 1)Study completedNCT02057445
What this trial is testing

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

Who this might be right for
Non-Hodgkins LymphomaHodgkins LymphomaLymphoproliferative Disorder
New York Medical College 1
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Not applicableStudy completedNCT05927558
What this trial is testing

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

Who this might be right for
B-cell Non Hodgkin LymphomaRelapseRefractory Lymphoma
Gruppo Italiano Malattie EMatologiche dell'Adulto 59
Not applicableStudy completedNCT00547196
What this trial is testing

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
City of Hope Medical Center 10
Not applicableNot Yet RecruitingNCT06879470
What this trial is testing

JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma

Who this might be right for
B-Non Hodgkin Lymphoma
He Huang 24
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Early research (Phase 1)Not Yet RecruitingNCT07032324
What this trial is testing

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )

Who this might be right for
B-Cell Non-Hodgkin Lymphoma
Qian Wenbin 27
Next Page